GOODPASTURE SYNDROME

Clinical trials for GOODPASTURE SYNDROME explained in plain language.

Never miss a new study

Get alerted when new GOODPASTURE SYNDROME trials appear

Sign up with your email to follow new studies for GOODPASTURE SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Terminated 1

New hope for rare kidney disease? trial tests imlifidase

Disease control Terminated

This study tested a new drug called imlifidase for people with severe Goodpasture disease, a rare condition where the immune system attacks the kidneys and lungs. The trial compared imlifidase plus standard care to standard care alone in 50 adults with poor kidney function. The g…

Matched conditions: GOODPASTURE SYNDROME

Phase: PHASE3 • Sponsor: Hansa Biopharma AB • Aim: Disease control

Last updated Jun 08, 2026 13:17 UTC

GOODPASTURE SYNDROME

Get alerted when new GOODPASTURE SYNDROME trials appear

New hope for rare kidney disease? trial tests imlifidase